Navarro, Merlindo D.
HRN: 06-78-66 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2023
AZITHROMYCIN 500MG TABLET (TAB)
10/26/2023
11/01/2023
PO
509mg/tab, 1tablet
Q24h
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes